Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sullivan

Showing results (1261-1270 of 1,433) with videos related to

Pageof 144
Sort By:
Antimicrobial Agents and Chemotherapy|August 10, 2016
Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric PatientsJohn S Bradley, Jon Armstrong, Antonio Arrieta, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 17, 2007
Antiviral and myocyte protective effects of murine interferon-beta and -{alpha}2 in coxsackievirus B3-induced myocarditis and epicarditis in Balb/c miceYi-Xin Wang, Valdeci da Cunha, Jon Vincelette, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2017
Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and ChildrenJulie Autmizguine, Chiara Melloni, Christoph P Hornik, et al.
Journal of Clinical Immunology|January 26, 2021
Infectious Complications Predict Premature CD8<sup>+</sup> T-cell Senescence in CD40 Ligand-Deficient PatientsJunghee J Shin, Jason Catanzaro, Jennifer R Yonkof, et al.
Clinical Pharmacology and Therapeutics|June 21, 2014
Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescentsD Gonzalez, C Melloni, R Yogev, et al.
Journal of Pharmacokinetics and Pharmacodynamics|February 14, 2018
A pharmacokinetic model for amiodarone in infants developed from an opportunistic sampling trial and published literature dataSamantha H Dallefeld, Andrew M Atz, Ram Yogev, et al.
Paediatric Drugs|July 24, 2021
Pharmacokinetics of Ceftazidime in Children and Adolescents with ObesityAnil R Maharaj, Huali Wu, Kanecia O Zimmerman, et al.
ACS Nano|March 27, 2024
Nanocavity-Mediated Purcell Enhancement of Er in TiO<sub>2</sub> Thin Films Grown via Atomic Layer DepositionCheng Ji, Michael T Solomon, Gregory D Grant, et al.
Journal of Neurological Surgery. Part B, Skull Base|November 19, 2016
STAT3 Inhibition as a Therapeutic Strategy for ChordomaAnthony C Wang, John H Owen, Waleed M Abuzeid, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 2020
Human Adenovirus 7-Associated Hemophagocytic Lymphohistiocytosis-like Illness: Clinical and Virological Characteristics in a Cluster of Five Pediatric CasesWilliam R Otto, Edward M Behrens, David T Teachey, et al.
Pageof 144

Showing results (1261-1270 of 1,433) with videos related to

Sort By:
Pageof 144
Antimicrobial Agents and Chemotherapy|August 10, 2016
Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric PatientsJohn S Bradley, Jon Armstrong, Antonio Arrieta, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 17, 2007
Antiviral and myocyte protective effects of murine interferon-beta and -{alpha}2 in coxsackievirus B3-induced myocarditis and epicarditis in Balb/c miceYi-Xin Wang, Valdeci da Cunha, Jon Vincelette, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2017
Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and ChildrenJulie Autmizguine, Chiara Melloni, Christoph P Hornik, et al.
Journal of Clinical Immunology|January 26, 2021
Infectious Complications Predict Premature CD8<sup>+</sup> T-cell Senescence in CD40 Ligand-Deficient PatientsJunghee J Shin, Jason Catanzaro, Jennifer R Yonkof, et al.
Clinical Pharmacology and Therapeutics|June 21, 2014
Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescentsD Gonzalez, C Melloni, R Yogev, et al.
Journal of Pharmacokinetics and Pharmacodynamics|February 14, 2018
A pharmacokinetic model for amiodarone in infants developed from an opportunistic sampling trial and published literature dataSamantha H Dallefeld, Andrew M Atz, Ram Yogev, et al.
Paediatric Drugs|July 24, 2021
Pharmacokinetics of Ceftazidime in Children and Adolescents with ObesityAnil R Maharaj, Huali Wu, Kanecia O Zimmerman, et al.
ACS Nano|March 27, 2024
Nanocavity-Mediated Purcell Enhancement of Er in TiO<sub>2</sub> Thin Films Grown via Atomic Layer DepositionCheng Ji, Michael T Solomon, Gregory D Grant, et al.
Journal of Neurological Surgery. Part B, Skull Base|November 19, 2016
STAT3 Inhibition as a Therapeutic Strategy for ChordomaAnthony C Wang, John H Owen, Waleed M Abuzeid, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 2020
Human Adenovirus 7-Associated Hemophagocytic Lymphohistiocytosis-like Illness: Clinical and Virological Characteristics in a Cluster of Five Pediatric CasesWilliam R Otto, Edward M Behrens, David T Teachey, et al.
Pageof 144